This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Allergan’s VISTABEL® (botulinum toxin type a) receives positive opinion from ansm for treatment of moderate to severe forehead lines in adult patients in 30 european countries
December 20, 2017
- Galderma to Present New Findings From Innovative Product Portfolio at the 2022 VCS Annual Symposium
- Anticipating Pain Points and Strategies for Solving Them Before They Arise
- Sinclair launches #ThePowerOf MaiLi for Eyes and Lips
- Prollenium® Medical Technologies acquires cosmetic aesthetic leaders SoftFil®
- Harpar Grace release the results of new Active Peel System clinical study